# Sutro Biopharma, Inc.: Form 8-K, filed Dec 27, 2021

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2021-12-27
- Accepted by EDGAR: Dec 27, 2021, 07:00 ET
- Period: 2021-12-24
- Accession: 0000950170-21-005353
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000095017021005353/stro-20211224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000095017021005353/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000095017021005353/stro-20211224.htm

Filed Dec 27, 2021.
Source: SEC EDGAR, the filing index for accession 0000950170-21-005353. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.